DOSSIER · 13F-HR · Q2 2026
Merck & Co., Inc.
$526M in tracked AUM across 13 positions as of Q2 2026.
M&
CIK 0000310158 · last filed Jun 30, 2026
AI Analysis · Q2 2026
Portfolio Overview
The filing for Merck & Co., Inc. (CIK: 0000310158) reveals a highly specialized, non-diversified investment portfolio with a distinct focus on the biotechnology sector. As of the reporting period ending September 30, 2025, the total portfolio value stood at approximately $171.31 million, spread across just 8 holdings. This represents a significant contraction in capital, with the portfolio value decreasing by 20.5% from the previous quarter's $215.60 million. ...
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology
Quarter at a glance — Q2 2026
Position-change comparison pending.
No quarter-over-quarter changes available.
Top 10 holdings
By portfolio weight as of Q2 2026.